Project Grant RF1NS140137

Award Date 9/24/24
Completion Date 8/31/26
Dollars Obligated $2.4M
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Aurora, CO 80045, USA
Similar Awards
This $3.61 million project grant from the National Institutes of Health's National Institute on Aging will fund research from July 2022 to June 2025 aimed at understanding and addressing neurovascular coupling dysfunction in Alzheimer's disease and Alzheimer's disease-related dementias. Specifically, the University of Colorado Denver will investigate the hypothesis that restoring neurovascular coupling can mitigate synaptic plasticity deterioration in the hippocampus and its behavioral...
This Project Grant award of $5,949,022, provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, will fund research to identify novel therapeutic targets for treating cerebral amyloid angiopathy (CAA) and vascular contributions to cognitive impairment and dementia (VCID). The research, led by the Jackson Laboratory with sub-awards to Emory University, Rush...
This federal Project Grant award, issued by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $4,693,249 to the University of California, Los Angeles (UCLA) to conduct research on defining the molecular spectrum of white matter vascular lesions that drive vascular cognitive impairment and dementia (VCID). The project aims to develop a better understanding of...
This $1,120,805 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders federal grant program (CFDA 93.853), will support research to investigate how prior SARS-CoV-2 infection may increase the risk of vascular contributions to cognitive impairment and dementia (VCID). The research aims to: Determine how prior SARS-CoV-2 infection influences blood-brain barrier...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $631,577.00 to the University of Miami to conduct research on the role of neutrophils in vascular inflammation and cognitive impairment in Alzheimer's disease (AD) and vascular contributions to cognitive impairment and dementia...
The National Institute on Aging (NIA) awarded a $471,885 Project Grant (CFDA 93.866 - Aging Research) to Oregon Health & Science University (OHSU) from June 1, 2025 to May 31, 2027. The project aims to investigate the mechanisms underlying brain vascular endothelial cell (BVEC) disruption following vascular brain injury, which can contribute to vascular cognitive impairment and dementia (VCID). Specifically, the project will test hypotheses related to how the glycosaminoglycan hyaluronan and...
This Project Grant award of $4,361,625 from the National Institute on Aging (CFDA 93.866 - Aging Research) supports a "VCID Center Without Walls for Understanding and Leveraging Small Vessel Cerebrovascular Disease Mechanisms in ADRD" at Washington University. The project aims to leverage advanced multi-omics and transcriptomic technologies to investigate the complex mechanisms underlying cerebral small vessel disease (CSVD) and its vascular contributions to dementia (VCID). Key...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) provides $185,913 to Trustees of Boston University to examine sex differences in vascular contributions to cognitive impairment and dementia (VCID) and Alzheimer's disease (AD). The research aims to identify sex-specific patterns of white matter integrity, functional brain connectivity, and cognitive...
This Project Grant award of $2,683,965 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) will support the development and optimization of an improved all-human cellular system, or "brain-chip", for studying Alzheimer's disease and related dementias (ADRDs). The key objectives are to: 1) define delivery conditions for introducing patient blood cells and plasma into...
This Project Grant award of $427,625 from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research to develop tools for studying proteome plasticity in brain endothelial cells. The goal is to elucidate the mechanisms by which changes in neuronal energy demands lead to reprogramming of signaling pathways that control brain blood flow, which is critical for...

This Project Grant award for $2,398,590.00, provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, will support research to investigate the role of brain microcirculation and capillary endothelial cell energetics in the development of vascular cognitive impairment and dementia (VCID) observed in Alzheimer's disease (AD) and AD-related dementias. The multidisciplinary research team from the University of Colorado-Denver will use advanced imaging, bioenergetics approaches, and multi-omics analysis to test the hypothesis that alterations in the extracellular matrix and epidermal growth factor receptor (EGFR) signaling impair mitochondrial function and ATP production in capillary endothelial cells, leading to neurovascular uncoupling and cognitive deficits. The research aims to provide a better understanding of the pathological mechanisms underlying VCID and identify potential therapeutic strategies. The project will be conducted from September 2024 through August 2026 at the University of Colorado-Denver.

Generated 7/1/25, 1:50 AM